Table 3 Diabetes complications and comorbidities according to subgroups created from the latent profile analysis (N = 147)
Variable | Total (N = 147) n (%) | Group 1 (n = 16) n (%) | Group 2 (n = 14) n (%) | Group 3 (n = 23) n (%) | Group 4 (n = 29) n (%) | Group 5 (n = 28) n (%) | Group 6 (n = 37) n (%) | P-value |
|---|---|---|---|---|---|---|---|---|
Nephropathy | 97 (66.0) | 13 (81.3) | 7 (50.0) | 15 (65.2) | 20 (69.0) | 17 (60.7) | 25 (67.6) | 0.584 |
Microangiopathy | 68 (46.3) | 5 (31.3) | 4 (28.6) | 9 (39.1) | 13 (44.8) | 12 (42.9) | 25 (67.6) | 0.060 |
Diabetic retinopathy | 43 (29.3) | 2 (12.5) | 1 (7.1) | 4 (17.4) | 10 (34.5) | 8 (28.6) | 18 (68.6) | 0.015 |
Diabetic neuropathy | 52 (35.9) | 3 (18.8) | 4 (28.6) | 7 (30.4) | 11 (39.3) | 9 (32.1) | 18 (50.0) | 0.297 |
Macroangiopathy | 81 (55.1) | 4 (25.0) | 6 (42.9) | 14 (60.9) | 15 (51.7) | 14 (50.0) | 28 (75.7) | 0.017 |
Coronary artery disease | 52 (35.4) | 3 (18.8) | 6 (42.9) | 8 (34.8) | 7 (24.1) | 9 (32.1) | 19 (51.4) | 0.149 |
Cerebro-vascular disease | 28 (23.0) | 1 (6.7) | 1 (7.7) | 7 (35.0) | 6 (23.1) | 4 (19.0) | 9 (33.3) | 0.208 |
Peripheral artery disease | 25 (17.0) | 1 (6.3) | 1 (7.1) | 3 (13.0) | 3 (10.3) | 7 (25.0) | 10 (27.0) | 0.252 |